TLR antagonists (Janus Biotherapeutics)

N/A

Report date: 2025/03/20 09:42:10
NME

Base Information

Drug NameTLR antagonists (Janus Biotherapeutics)
Drug Alias NameTLR7/8/9 antagonists (Janus Biotherapeutics)TLR7/8/9 antagonists (Janus Biotherapeutics/Roche)TLR antagonists (Janus Biotherapeutics/Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 9 antagonistsToll like receptor 8 antagonists
TargetsToll like receptor 9Toll like receptor 7Toll like receptor 8
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanus Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanus Biotherapeutics IncRoche Holding Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A